Article Text

This article has a correction. Please see:

Download PDFPDF
Recent advances in understanding haemochromatosis: a transition state

Abstract

Mutations in the hepcidin gene HAMP and the hemojuvelin gene HJV have recently been shown to result in juvenile haemochromatosis (JH). Hepcidin is an antimicrobial peptide that plays a key role in regulating intestinal iron absorption. Hepcidin levels are reduced in patients with haemochromatosis due to mutations in the HFE and HJV genes. Digenic inheritance of mutations in HFE and HAMP can result in either JH or hereditary haemochromatosis (HH) depending upon the severity of the mutation in HAMP. Here we review these findings and discuss how understanding the different types of haemochromatosis and our increasing knowledge of iron metabolism may help to elucidate the host’s response to infection.

  • ACD, anaemia of chronic disease
  • AD, Alzheimer’s disease
  • β2M, β2-microglobulin
  • Cp−/− mice, ceruloplasmin null mice
  • JH, juvenile haemochromatosis
  • HH, hereditary haemochromatosis
  • IEL, intra-epithelial lymphocytes
  • IL-6, interleukin 6
  • IRE, iron responsive element
  • MHC, major histocompatibility complex
  • NF-κB, nuclear factor κB
  • NRAMP1, natural resistance associated macrophage protein 1
  • Pcm, polycythaemic mice
  • PKAN, pantothenate kinase associated neurodegeneration
  • SLC11A1, solute carrier family 1 member 1
  • SLC11A2, solute carrier family 1 member 2
  • TfR2, transferrin receptor 2
  • TFR2, transferrin receptor 2 gene
  • ferroportin
  • haemochromatosis
  • hemojuvelin
  • hepcidin
  • HFE

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Correction
    BMJ Publishing Group Ltd